(Q36421968)

English

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Ganesh S

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Sier CF

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Heerding MM

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

van Krieken JH

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Griffioen G

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Welvaart K

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

van de Velde CJ

7

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Verheijen JH

8

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Lamers CB

9

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Verspaget HW

10

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

75

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

12

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1793-1801

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.1997.306

0 references

Protein measurement with the Folin phenol reagent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

The spread of rectal cancer and its effect on prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Plasminogen activator inhibitor-2: prognostic relevance in 1012 patients with primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Regression analysis of prognostic factors in colorectal cancer after curative resections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Plasminogen activators, tissue degradation, and cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Plasminogen activation and regulation of pericellular proteolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Colon, rectum, and anus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Role of adjuvant therapy in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Effective surgical adjuvant therapy for high-risk rectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

The natural history of colorectal cancer. Opportunities for intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Colorectal carcinoma: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

The plasminogen activator/plasmin system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Surgical excision alone is adequate treatment for primary colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Staging of cancer of the colon and rectum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Colon cancer overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

30 September 2017

Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

28 June 2018

Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

28 June 2018

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

28 June 2018

Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type 1 inhibitor in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

28 June 2018

Colonic carcinoma.A quantitative assessment of lymphocyte infiltration at the periphery of colonic tumors related to prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

28 June 2018

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

21 September 2018

Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

21 September 2018

Prognostic significance of histologic host response in cancer of the large bowel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223607

21 September 2018

Evolution in the pathologic staging of carcinoma of the colon

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spinal cord injury: impact on clients' significant others

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eosinophil infiltration of human colonic carcinomas as a prognostic indicator

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of tissue-type plasminogen activator in human endothelial cell cultures by use of an enzyme immunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: the controversy continues

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Urokinase-type plasminogen activator and outcome in Dukes' B colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the plasminogen activation system in patients with gastric carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colorectal carcinoma. A survey of 1345 cases 1950-1984

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators and tumor development in the human colon: activity levels in normal mucosa, adenomatous polyps, and adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postoperative adjuvant chemotherapy or BCG for colon cancer: results from NSABP protocol C-01

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival of patients with cancers of the colon and rectum?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The urokinase type of plasminogen activator in cancer of digestive tracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators in the intestine of patients with inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of urokinase-type plasminogen activator by antibodies: the effect on dissemination of a human tumor in the nude mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: possible roles in tumor progression and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and pathologic prognostic indicators in colorectal cancer. A population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of plasminogen activator inhibitor mRNA levels in lipopolysaccharide-stimulated human monocytes. Correlation with production of the protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Staging of colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of adjuvant chemotherapy for colorectal cancer. Can molecular markers play a role in predicting prognosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9192984

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.306

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36421968&oldid=1590504120"